Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIL and IL-2 in Metastatic Melanoma
NCT00604136Phase 2Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Jul 2008
- Primary completion
- Dec 2019
- Modality
- Monoclonal Antibodies, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous tumor-infiltrating lymphocytes in melanoma, sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
autologous tumor-infiltrating lymphocytes
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00604136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00604136.